Journal of Gastrointestinal Cancer最新文献

筛选
英文 中文
Microsatellite Stable Colorectal Tumours in Patients with Lynch Syndrome: A Case Report and Systematic Review Analysing Clinical Features and Implications for Immunotherapy. Lynch综合征患者的微卫星稳定结直肠肿瘤:1例报告和系统综述,分析临床特征和免疫治疗的意义。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2025-03-25 DOI: 10.1007/s12029-025-01203-1
Fani Kapoulitsa, Davide Mauri, Konstantinos K Tsilidis, Konstantinos Katsanos, Eleni Timotheadou, Maria Smaragdi Vlachou, Konstantinos Kamposioras
{"title":"Microsatellite Stable Colorectal Tumours in Patients with Lynch Syndrome: A Case Report and Systematic Review Analysing Clinical Features and Implications for Immunotherapy.","authors":"Fani Kapoulitsa, Davide Mauri, Konstantinos K Tsilidis, Konstantinos Katsanos, Eleni Timotheadou, Maria Smaragdi Vlachou, Konstantinos Kamposioras","doi":"10.1007/s12029-025-01203-1","DOIUrl":"10.1007/s12029-025-01203-1","url":null,"abstract":"<p><strong>Purpose: </strong>Lynch syndrome is an autosomal dominant genetic disorder associated with early-onset colorectal cancer (CRC), endometrial cancer and other malignancies. This condition is defined by deficient DNA mismatch repair and high microsatellite instability (dMMR/MSI-high), exhibiting a substantial response to immunotherapy. However, microsatellite-stable (MSS) tumours may infrequently occur in individuals with Lynch syndrome. Our aim was to evaluate the efficacy of immunotherapy in patients with Lynch Syndrome and dMMR/MSS colorectal cancer.</p><p><strong>Methods: </strong>A systematic review of the literature in medical databases, major related conferences and relevant oncology journals was conducted to identify the available evidence. Medical records from the Medical and Clinical Oncology Department of the University Hospital of Ioannina were also reviewed.</p><p><strong>Results: </strong>Four cases of MSS colorectal cancer associated with Lynch syndrome and MSH6 germline mutation were identified. Three of these four patients were treated with immune checkpoint inhibitors. Two patients with metastatic disease experienced disease progression, but one patient who received neoadjuvant immunotherapy achieved a partial response. All four patients were diagnosed with colorectal cancer in ages younger than 52 (16-51 years old).</p><p><strong>Conclusion: </strong>MSS CRC tumours in patients with Lynch syndrome is an infrequent phenomenon and under-represented in the literature. The limited efficacy of immune checkpoint inhibitors is highlighted in this rare subset of patients.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"56 1","pages":"86"},"PeriodicalIF":1.6,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11937178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143710185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative Radiotherapy in Patients with Gastric and Gastro-Oesophageal Cancer: A Systematic Review and Meta-analysis. 胃癌和胃食管癌患者术前放疗:系统回顾和荟萃分析。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2025-03-24 DOI: 10.1007/s12029-025-01204-0
Gustavo Tadeu Freitas Uchôa Matheus, Pedro Henrique de Souza Wagner, João Arthur Cerqueira Taumaturgo, Shi Juin Lam, Francisco Cezar Aquino de Moraes
{"title":"Preoperative Radiotherapy in Patients with Gastric and Gastro-Oesophageal Cancer: A Systematic Review and Meta-analysis.","authors":"Gustavo Tadeu Freitas Uchôa Matheus, Pedro Henrique de Souza Wagner, João Arthur Cerqueira Taumaturgo, Shi Juin Lam, Francisco Cezar Aquino de Moraes","doi":"10.1007/s12029-025-01204-0","DOIUrl":"https://doi.org/10.1007/s12029-025-01204-0","url":null,"abstract":"<p><strong>Background: </strong>Gastric (GC) and gastroesophageal junction (GEJ) cancers are among the most prevalent digestive cancers, characterized by a poor prognosis, particularly in advanced stages, where the 5-year survival rate remains below 20%. While surgery is still the standard treatment, its limited ability to lower recurrence rates highlights the necessity for effective perioperative therapies. In this context, Radiotherapy (RT) and chemoradiotherapy (CRT) have been investigated for their potential to improve tumor control, pathologic complete response (pCR), and overall survival (OS) in advanced GC. This systematic review and meta-analysis aimed to assess the efficacy and safety of preoperative RT/CRT on key clinical outcomes in patients with GC, focusing on pathologic complete response (pCR), overall survival (OS), and postoperative complications, such as anastomotic leaks and postoperative mortality.</p><p><strong>Methods: </strong>A systematic search of PubMed, Embase, and Web of Science databases was conducted for randomized controlled trials and single-arm studies comparing preoperative RT/CRT with chemotherapy or surgery alone. Outcomes were pooled using risk ratios (RRs) or hazard ratios (HRs) with 95% confidence intervals (CIs), and heterogeneity was assessed using I<sup>2</sup> statistics. Furthermore, quality assessment was performed using RoB 2 and ROBINS-I tools. We also utilized tools to enhance the interpretation and understanding of the meta-analysis results, including GRADE, the leave-one-out method, Baujat and Doi plots.</p><p><strong>Results: </strong>Ten studies including 6 RCTs and 4 single-arm studies, comprising 2,138 patients were included. CRT significantly improved pCR rates compared to control groups (RR 2.72; 95% CI 1.89-3.92; p < 0.000001; I<sup>2</sup> = 0%), with a pCR rate of 21% in single-arm analysis. No statistical significance was observed in the hazard ratio analysis for OS (HR 0.84; 95% CI 0.65-1.10; p = 0.209; I<sup>2</sup> = 67%), including the subgroup analyses at three (RR 1.15; 95% CI 0.93-1.43; p = 0.183; I<sup>2</sup> = 70%) and five years (RR 1.23; 95% CI 1.00-1.51; p = 0.051; I<sup>2</sup> = 58%). Moreover, the rates for anastomotic leaks (RR 0.86; 95% CI 0.66-1.14; p = 0.294; I<sup>2</sup> = 0%) and postoperative mortality (RR 0.88; 95% CI 0.46-1.70; p = 0.71; I<sup>2</sup> = 25%) showed no significant differences between groups, with low event rates in single-arm studies, 7% and 3%, respectively.</p><p><strong>Conclusion: </strong>Preoperative CRT significantly improves pCR rates, highlighting its potential as a valuable strategy in tumor downstaging. However, it does not enhance survival outcomes, while notably, it does not increase surgical complications. Future studies incorporating biomarkers and standardized protocols are essential to refine patient selection, ensuring optimized treatment strategies and maximizing clinical benefits.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"56 1","pages":"84"},"PeriodicalIF":1.6,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143692354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Status of Gastrectomy for Gastric Cancer in Oldest-old Patients Aged 85 Years or Older. 85岁及以上高龄胃癌患者胃切除术的现状。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2025-03-22 DOI: 10.1007/s12029-025-01205-z
Kazuaki Matsui, Yoshiki Kawaguchi, Takahiro Iwai, Yukiko Torizaki, Yoko Adachi, Hirofumi Shimoda, Takehiro Shimada, Yasuhito Sekimoto, Hidejiro Urakami, Shiko Seki
{"title":"Current Status of Gastrectomy for Gastric Cancer in Oldest-old Patients Aged 85 Years or Older.","authors":"Kazuaki Matsui, Yoshiki Kawaguchi, Takahiro Iwai, Yukiko Torizaki, Yoko Adachi, Hirofumi Shimoda, Takehiro Shimada, Yasuhito Sekimoto, Hidejiro Urakami, Shiko Seki","doi":"10.1007/s12029-025-01205-z","DOIUrl":"https://doi.org/10.1007/s12029-025-01205-z","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to investigate the safety of gastrectomy for gastric cancer in oldest-old patients aged ≥ 85 years.</p><p><strong>Methods: </strong>This study retrospectively analyzed the patients aged ≥ 85 years who diagnosed with gastric cancer between 2008 and 2022. The study patients were divided into three groups: a surgery group, an endoscopic submucosal dissection (ESD) group, and a non-surgery and non-ESD group (n = 64, 57, and 152). Surgical outcomes and 3-year overall and recurrence-free survival (OS and RFS) were investigated.</p><p><strong>Results: </strong>In the surgery group, the study cohort comprised 30 males and 34 females with a median age of 87 years. Distal, proximal, and total gastrectomy (DG, PG, and TG) were performed in 54, 1, and 9 patients, respectively. There were 27, 16, 17, and 4 patients with pStage I, II, III, and IV, respectively. Thirty-day morbidity with Clavien-Dindo grade ≥ 3 and 30-day mortality were 12.5% and 3.1%, respectively. Kaplan-Meier curves for the 3-year OS and RFS demonstrated that survival curves worsened with increasing pStage (p = 0.005 and p < 0.001, respectively). In multivariate analyses for the 3-year OS and RFS, TG and pStage ≥ III were independent risk factors (p = 0.028 and 0.011 in OS, p = 0.021 and 0.001 in RFS). In comparisons of 3-year OSs among the three groups in each cStage, survivals in the surgery group were consistently better than those in the non-surgery and non-ESD group in cStages I to III (p < 0.001, 0.001, and < 0.001 in cStage I, II, and III, respectively).</p><p><strong>Conclusion: </strong>Our findings suggest that the radical gastrectomy for gastric cancer can be performed safely and has a chance to improve survival even in the oldest-old patients aged ≥ 85 years.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"56 1","pages":"83"},"PeriodicalIF":1.6,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143692283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative Prediction of Sarcopenia in Patients Scheduled for Gastric and Colorectal Cancer Surgery. 胃、结直肠癌手术患者肌肉减少症的术前预测
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2025-03-21 DOI: 10.1007/s12029-025-01206-y
Beijia Zhou, Yanjun Song, Chen Chen, Xiaotian Chen, Tingting Tao
{"title":"Preoperative Prediction of Sarcopenia in Patients Scheduled for Gastric and Colorectal Cancer Surgery.","authors":"Beijia Zhou, Yanjun Song, Chen Chen, Xiaotian Chen, Tingting Tao","doi":"10.1007/s12029-025-01206-y","DOIUrl":"https://doi.org/10.1007/s12029-025-01206-y","url":null,"abstract":"<p><strong>Introduction: </strong>Sarcopenia negatively impacts surgical outcomes in gastrointestinal cancer patients, yet practical preoperative screening tools are lacking. The CRP/ALB ratio, a novel biomarker of systemic inflammation and nutritional status, may enhance sarcopenia prediction but remains underexplored in surgical oncology. This study aims to identify the predictors for preoperative sarcopenia prediction in gastric and colorectal cancer patients.</p><p><strong>Methods: </strong>This retrospective study analyzed 145 patients undergoing curative surgery (2019-2021). Sarcopenia was defined by sex-specific CT-measured L3 skeletal muscle index (cutoffs, male ≤ 40.8 cm<sup>2</sup>/m<sup>2</sup>; female ≤ 34.9 cm<sup>2</sup>/m<sup>2</sup>). Multivariable logistic regression identified predictors, with model performance assessed via ROC analysis and Cohen's Kappa.</p><p><strong>Results: </strong>The cohort (median age 64 years; 73.8% male) comprised 66 gastric (45.5%) and 79 colorectal (54.5%) cancer patients, with 29 (20%) diagnosed with sarcopenia. Sarcopenic patients exhibited a higher NRS 2002 score (P < 0.001), lower PNI score (P < 0.05), and higher CRP/ALB ratio (P < 0.05). Multivariate logistic regression analysis results showed that CRP/ALB ratio (OR = 3.084, 95% CI 1.071-8.882, P = 0.037), age (OR = 1.074, 95% CI 1.021-1.130, P = 0.006), and BMI (OR = 0.667, 95% CI 0.542-0.820, P = 0.000) were associated with the increased risk of sarcopenia. The combined model achieved superior discrimination (AUC = 0.854, 95% CI 0.770-0.937), yielding 75.86% sensitivity and 84.82% specificity at optimal cutoff value - 1.0340, and a Cohen's Kappa coefficient of 0.542 when compared to CT results.</p><p><strong>Conclusion: </strong>The CRP/ALB ratio combined with BMI and age is utilized as a convenient and effective tool for preoperative sarcopenia screening. This model-driven approach provides robust strategies to facilitate preoperative interventions, optimize perioperative care, and enhance long-term oncological outcomes for patients undergoing gastric and colorectal cancer surgery.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"56 1","pages":"82"},"PeriodicalIF":1.6,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143673976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression Levels of Plasma YRNAs in Colorectal Cancer as a Potential Noninvasive Biomarker. 血浆YRNAs在结直肠癌中的表达水平作为潜在的无创生物标志物。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2025-03-19 DOI: 10.1007/s12029-025-01197-w
Eman Tayae, Eman M Osman, Marwa R Tawfik, Neamat Hegazy, Marwa Moaaz, Rasha A Ghazala
{"title":"Expression Levels of Plasma YRNAs in Colorectal Cancer as a Potential Noninvasive Biomarker.","authors":"Eman Tayae, Eman M Osman, Marwa R Tawfik, Neamat Hegazy, Marwa Moaaz, Rasha A Ghazala","doi":"10.1007/s12029-025-01197-w","DOIUrl":"https://doi.org/10.1007/s12029-025-01197-w","url":null,"abstract":"<p><strong>Purpose: </strong>Colorectal cancer (CRC) is identified as the second leading cause of cancer-associated deaths worldwide. Therefore, there is ongoing research to discover new potential biomarkers enabling early and noninvasive diagnosis of the disease. YRNAs, a novel class of non-coding RNAs, have been identified as a new player in carcinogenesis and an independent class of clinical biomarkers in various malignancies. Nevertheless, the role of plasma YRNAs in CRC diagnosis and prognosis remains unknown. Therefore, the current study aimed to investigate the clinical significance of plasma YRNAs as a noninvasive biomarker for CRC.</p><p><strong>Methods: </strong>Plasma YRNAs expression was assessed in 50 newly diagnosed CRC patients as well as 50 age- and sex-matched healthy controls using quantitative reverse transcription polymerase chain reaction.</p><p><strong>Results: </strong>All plasma YRNAs expression levels were significantly higher in CRC patients than in controls. A significant correlation was observed between YRNA1 and YRNA3, and between YRNA1 and YRNA4. However, no significant correlation between YRNA1 and YRNA5 was identified. Plasma YRNA1 expression showed the highest diagnostic performance for the detection of CRC using the receiver operating characteristic curve analysis, with a sensitivity of 92% and a specificity of 90%. Nevertheless, when the four YRNAs were combined in a single ROC analysis, sensitivity decreased to 80%, while the specificity remained virtually unchanged. Moreover, significant association was observed between plasma YRNA1 and YRNA3 and tumor stage, grade, lymph node presence, metastasis, and lymphovascular invasion.</p><p><strong>Conclusions: </strong>Plasma YRNA may serve as a potential noninvasive biomarker for the diagnosis and prognosis of CRC with high sensitivity and specificity vs. healthy controls.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"56 1","pages":"81"},"PeriodicalIF":1.6,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143663560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the Need for Additional Surgery After Non-Curative Endoscopic Resection in Patients with Remnant Gastric Cancer. 评估残胃癌患者非治愈性内镜切除后额外手术的必要性。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2025-03-17 DOI: 10.1007/s12029-025-01199-8
Tatsunori Minamide, Hiroyuki Ono, Noboru Kawata, Yuki Maeda, Masao Yoshida, Yoichi Yamamoto, Kazunori Takada, Yoshihiro Kishida, Sayo Ito, Kenichiro Imai, Kinichi Hotta, Junya Sato, Hirotoshi Ishiwatari, Hiroyuki Matsubayashi, Akifumi Notsu, Etsuro Bando
{"title":"Evaluating the Need for Additional Surgery After Non-Curative Endoscopic Resection in Patients with Remnant Gastric Cancer.","authors":"Tatsunori Minamide, Hiroyuki Ono, Noboru Kawata, Yuki Maeda, Masao Yoshida, Yoichi Yamamoto, Kazunori Takada, Yoshihiro Kishida, Sayo Ito, Kenichiro Imai, Kinichi Hotta, Junya Sato, Hirotoshi Ishiwatari, Hiroyuki Matsubayashi, Akifumi Notsu, Etsuro Bando","doi":"10.1007/s12029-025-01199-8","DOIUrl":"https://doi.org/10.1007/s12029-025-01199-8","url":null,"abstract":"<p><strong>Purpose: </strong>Completion total gastrectomy is considered an additional treatment after non-curative endoscopic resection for remnant gastric cancer. However, its high invasiveness remains a concern. This study aimed to assess the necessity of additional surgery after non-curative endoscopic submucosal dissection in patients with remnant gastric cancer.</p><p><strong>Methods: </strong>This study included patients who underwent non-curative endoscopic submucosal dissection for remnant gastric cancer between September 2002 and January 2018. The eCura system was used to stratify the risk of lymph node metastasis into low, intermediate, or high. The overall survival, disease-specific survival, and long-term clinical course were analyzed.</p><p><strong>Results: </strong>Among the 46 patients analyzed, 15 underwent additional completion total gastrectomy, whereas 31 were only followed up. Within a median follow-up period of 62.5 months, the additional surgery and follow-up groups showed 5-year overall survival rates of 79.4% and 76.8% (P = 0.93) and disease-specific survival rates of 92.9% and 92.7% (P = 0.98). A total of 19 low-, 8 intermediate-, and 4 high-risk patients in the follow-up group achieved 5-year disease-specific survival rates of 100%, 100%, and 33.3%. Significant differences were observed in the disease-specific survival between the low- and high-risk patients (P < 0.001) and between the intermediate- and high-risk patients (P = 0.02).</p><p><strong>Conclusion: </strong>Risk stratification using the eCura system allows for individualized treatment decisions, with follow-up being a viable option for low- and intermediate-risk patients and additional surgery recommended for high-risk patients after non-curative endoscopic submucosal dissection for remnant gastric cancer.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"56 1","pages":"80"},"PeriodicalIF":1.6,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143649249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-Grade Cystic Mucinous Neoplasm of the Colon: A New Entity? Case Report and Review of Literature. 结肠低级别囊性黏液瘤:一种新的肿瘤?病例报告及文献回顾。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2025-03-15 DOI: 10.1007/s12029-025-01201-3
Cesar Reategui Sanchez, Roberto Secchi Del Rio, Isabel Dos Santos Marques, Mary R Schwartz, Rachel Schiesser, Eric M Haas
{"title":"Low-Grade Cystic Mucinous Neoplasm of the Colon: A New Entity? Case Report and Review of Literature.","authors":"Cesar Reategui Sanchez, Roberto Secchi Del Rio, Isabel Dos Santos Marques, Mary R Schwartz, Rachel Schiesser, Eric M Haas","doi":"10.1007/s12029-025-01201-3","DOIUrl":"https://doi.org/10.1007/s12029-025-01201-3","url":null,"abstract":"<p><p>Low-grade cystic mucinous neoplasm of the sigmoid colon has never been previously reported and a classification for such a tumor does not currently exist. Here, we present a case of low-grade cystic mucinous neoplasm of the sigmoid colon and discuss the differential diagnosis especially as it relates to clinical management. Our case is a 68-year-old male who presented with anemia and a history of a lower gastrointestinal tract bleed. He denied abdominal pain and weight loss. A colonoscopy was done for further investigation, and he was found to have a 4-cm nonbleeding submucosal mass in the descending colon. Mucosal biopsies were inconclusive. An MRI of the abdomen and pelvis showed a 7.4 × 4.6 cm complex fluid collection involving the mid sigmoid colon with extensive diverticulosis and wall thickening of the sigmoid colon. The differential diagnosis included sequela of diverticulitis vs. neoplasm. Due to the increased risk of obstruction or perforation, a sigmoid resection was recommended. The patient underwent a robotic low anterior resection (LAR). Histological examination demonstrated a cystic mucinous neoplasm filled with acellular mucin and lined by pseudostratified columnar cells with low-grade dysplasia. The tumor involved the muscularis propria and subserosa. Cystic mucinous neoplasm of the colon is not currently recognized among tumors of the colon. Its malignant potential is uncertain. This is the first case report describing a cystic mucinous neoplasm of the sigmoid colon. Recognition of this unusual tumor can help to guide appropriate clinical management and guide further treatment.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"56 1","pages":"79"},"PeriodicalIF":1.6,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age-Related Differences in Gastric Adenocarcinoma from 2000-2020: A SEER Database Analysis. 2000-2020年胃腺癌的年龄相关差异:SEER数据库分析
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2025-03-13 DOI: 10.1007/s12029-025-01168-1
Abdul Qahar Khan Yasinzai, Anwaar Saeed
{"title":"Age-Related Differences in Gastric Adenocarcinoma from 2000-2020: A SEER Database Analysis.","authors":"Abdul Qahar Khan Yasinzai, Anwaar Saeed","doi":"10.1007/s12029-025-01168-1","DOIUrl":"https://doi.org/10.1007/s12029-025-01168-1","url":null,"abstract":"<p><strong>Introduction: </strong>Gastric cancer (GC) is the 5th most common malignancy worldwide. Adenocarcinoma accounts for 95% of all GC. While most cases of gastric adenocarcinoma (GAC) arise in older age males, a significant proportion of biological disparity exists between different ages. In this study, we aim to compare the demographics and prognostic outcomes of different ages of patients with GAC.</p><p><strong>Methods: </strong>This retrospective study utilized the GAC cases abstracted from the Surveillance, Epidemiology, and End Results Program's 17 registries dataset from 2000 to 2020. Cases were divided into different age group brackets to comparatively explore characteristics of GAC.</p><p><strong>Results: </strong>A total of 103,674 cases were identified. The median age was 69 years, with a significant proportion 39.7% (n = 41,154) falling within the 66-80 age bracket cases. Female proportions were higher in the ≤ 35 years age group 47.2% (n = 960) and ≥ 81 years age group 45.7% (n = 9,695). About 45.1% (n = 916) of ≤ 35 years age group cases were Hispanic, while 60% (n = 12,715) of ≥ 81 years age group cases were non-Hispanic White. Ages between 51-65 and 66-80 years had higher proportions of liver metastasis 17% and 16% than their younger and older peers. Age ≤ 35 years cases are more likely to present at cardia 20.5%. Male gender had the worst survival across all age groups, with the worst in the ≤ 35 age group hazard ratio (H.R) 1.22(1.007 - 1.250 p < 0.001). Black had the worst survival across all ages, with the worst in the ≤ 35 years age group H.R 1.405 (1.164 - 1.696 p < 0.001). When plotted against other races in each age group, Hispanics had poor survival at young ages H.R 1.224 (1.069 - 1.401) and superior survival at older ages, with H.R 0.944 (0.902 - 0.987) in the ≥ 81 age group. Tumors located in the greater curvature and overlapping lesions demonstrated worse prognosis compared to cardia. Conversely, tumors in the pylorus and lesser curvature generally exhibited better prognosis.</p><p><strong>Conclusion: </strong>In the United States GAC predominantly affects older adults, but early-onset cases exhibit aggressive histologies and poor survival, particularly more common in Hispanics. Black individuals face the worst survival outcomes across all age groups. Gender inclination towards males shrinks at the extremes of ages. At different age brackets, the demographics and prognosis changes, necessitating customized interventions.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"56 1","pages":"78"},"PeriodicalIF":1.6,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143624921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Recurrence of Colorectal Liver Metastasis (Number ≤ 5 and Largest Diameter ≤ 3 cm) after Resection or Thermal Ablation: a Multi-center Study of Patterns, Safety, Survival and Risk Factors. 结直肠癌肝转移灶(数量≤5个,最大直径≤3cm)切除或热消融后早期复发:多中心模式、安全性、生存率及危险因素研究
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2025-03-12 DOI: 10.1007/s12029-025-01200-4
Yaqing Kong, Xiaoyu Huang, Xiaojing Cao, Fan Tang, Xiang Zhou
{"title":"Early Recurrence of Colorectal Liver Metastasis (Number ≤ 5 and Largest Diameter ≤ 3 cm) after Resection or Thermal Ablation: a Multi-center Study of Patterns, Safety, Survival and Risk Factors.","authors":"Yaqing Kong, Xiaoyu Huang, Xiaojing Cao, Fan Tang, Xiang Zhou","doi":"10.1007/s12029-025-01200-4","DOIUrl":"https://doi.org/10.1007/s12029-025-01200-4","url":null,"abstract":"<p><strong>Objective: </strong>To compare early recurrence patterns, safety, survival and investigate the clinical risk factors of early recurrence (ER) after liver resection or thermal ablation (TA) for patients with colorectal liver metastases (CRLM) with number ≤ 5 and largest diameter ≤ 3 cm.</p><p><strong>Materials and methods: </strong>This retrospective study included patients with CRLM who underwent liver resection or TA between January 2016 and December 2021 at two hospitals in China. The Kaplan-Meier method and log-rank test were used to assess recurrence-free survival (RFS) and overall survival (OS). Risk factors for ER were analysed using univariate and multivariate Cox regression analyses.</p><p><strong>Results: </strong>303 patients with 632 liver metastases were enrolled. The most common early recurrence pattern was intrahepatic recurrence (IHR) in resection group and TA group. There was no significant difference in 6-month RFS rate (65.81% vs 66.23%) and median OS (P = 0.10) between two groups. Patients without ER had better OS than those with ER (P < 0.05). The incidence of serious complications (P = 0.013), length of hospitalization (P < 0.01), and albumin-bilirubin (ALBI) score (P = 0.038) in TA group were significantly better than resection group. The diameter of liver metastases (HR: 4.89, 95% CI: 1.16-20.60; P = 0.031) and clinical risk score (CRS) (HR: 1.86, 95% CI: 1.06-3.25; P = 0.029) were independent risk factors for ER.</p><p><strong>Conclusion: </strong>For CRLM with largest diameter ≤ 3 cm and number ≤ 5, the efficacy of receiving resection or TA is comparable, and the safety of TA is better. TA may be considered as the first-line local treatment option for patients with CRLM.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"56 1","pages":"77"},"PeriodicalIF":1.6,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143615664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colorectal Cancer Surgery During Summer Holidays: How Safe Is It? 暑期大肠癌手术:安全吗?
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2025-03-06 DOI: 10.1007/s12029-025-01198-9
Fatah Tidadini, Jean-Louis Quesada, Bertrand Trilling, Juliette Fischer, Pierre-Yves Sage, Jean-Luc Faucheron
{"title":"Colorectal Cancer Surgery During Summer Holidays: How Safe Is It?","authors":"Fatah Tidadini, Jean-Louis Quesada, Bertrand Trilling, Juliette Fischer, Pierre-Yves Sage, Jean-Luc Faucheron","doi":"10.1007/s12029-025-01198-9","DOIUrl":"https://doi.org/10.1007/s12029-025-01198-9","url":null,"abstract":"","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"56 1","pages":"76"},"PeriodicalIF":1.6,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信